Betimol (timolol ophthalmic solution) 0.5%
Recall D-0374-2024, part of FDA recall event 94146. See Thea Pharma's company page.
Thea Pharma, Inc. started this Class II drug recall on Mar 5, 2024 (voluntary: firm initiated); FDA lists it as terminated, terminated Jun 30, 2025.
- Classification: Class II
- Started: Mar 5, 2024
- Status: Terminated
Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
- Product
- Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15
- Quantity
- 5,476 bottles
- Lots and codes
- Lot #: 435019, Exp. Date 11/2024
- Distribution
- Product was distributed nationwide within the United States
- Recalling firm
- Thea Pharma, Inc., Waltham, MA, United States
- How the firm notified
- Letter
- FDA classified
- Mar 11, 2024
Newest first, one product per recall event; search them all
- iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma…D-0500-2026 · Class II · Apr 23, 2026 · Ongoing
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports